Moreover, soluble endoglin levels were reduced after a series of two aphereses, suggesting that soluble endoglin serves as an indicator of a beneficial and sufficient procedure in patients with familial hypercholesterolemia [20]. The gene discussed is ENG; the disease is familial hypercholesterolemia.